Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections
Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections
About this item
Full title
Author / Creator
Zhang, Chao , Wang, Yifan , Zhu, Yuanfei , Liu, Caixuan , Gu, Chenjian , Xu, Shiqi , Wang, Yalei , Zhou, Yu , Wang, Yanxing , Han, Wenyu , Hong, Xiaoyu , Yang, Yong , Zhang, Xueyang , Wang, Tingfeng , Xu, Cong , Hong, Qin , Wang, Shutian , Zhao, Qiaoyu , Qiao, Weihua , Zang, Jinkai , Kong, Liangliang , Wang, Fangfang , Wang, Haikun , Qu, Di , Lavillette, Dimitri , Tang, Hong , Deng, Qiang , Xie, Youhua , Cong, Yao and Huang, Zhong
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
The ongoing pandemic of coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Neutralizing antibodies against SARS-CoV-2 are an option for drug development for treating COVID-19. Here, we report the identification and characterization of two groups of mouse neutralizing monoclonal antibodies...
Alternative Titles
Full title
Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections
Authors, Artists and Contributors
Author / Creator
Wang, Yifan
Zhu, Yuanfei
Liu, Caixuan
Gu, Chenjian
Xu, Shiqi
Wang, Yalei
Zhou, Yu
Wang, Yanxing
Han, Wenyu
Hong, Xiaoyu
Yang, Yong
Zhang, Xueyang
Wang, Tingfeng
Xu, Cong
Hong, Qin
Wang, Shutian
Zhao, Qiaoyu
Qiao, Weihua
Zang, Jinkai
Kong, Liangliang
Wang, Fangfang
Wang, Haikun
Qu, Di
Lavillette, Dimitri
Tang, Hong
Deng, Qiang
Xie, Youhua
Cong, Yao
Huang, Zhong
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c3382a0b06624f9aa3dc99ff11e7fed0
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c3382a0b06624f9aa3dc99ff11e7fed0
Other Identifiers
ISSN
2041-1723
E-ISSN
2041-1723
DOI
10.1038/s41467-020-20465-w
